Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinib

被引：16
|
作者：
Zhu, You-Cai [1 ]
Wang, Wen-Xian [2 ]
Xu, Chun-Wei [3 ]
Tan, Qing-He [4 ]
Li, Jian-Ying [4 ]
Zhuang, Wu [5 ]
Song, Zheng-Bo [2 ]
Du, Kai-Qi [1 ]
Chen, Gang [3 ]
Lv, Tang-Feng [6 ]
Song, Yong [6 ]
机构：
[1] Zhejiang Rongjun Hosp, Dept Thorac Dis Diag & Treatment Ctr, Jiaxing 314000, Peoples R China
[2] Zhejiang Canc Hosp, Dept Chemotherapy, 1 Banshan East St, Hangzhou 310022, Zhejiang, Peoples R China
[3] Fujian Med Univ, Canc Hosp, Fujian Canc Hosp, Dept Pathol, Fuzhou 350014, Fujian, Peoples R China
[4] Nantong Tumor Hosp, Dept Oncol, Nantong 226361, Peoples R China
[5] Fujian Med Univ, Canc Hosp, Fujian Canc Hosp, Dept Med Thorac Oncol, Fuzhou 350014, Fujian, Peoples R China
[6] Jinling Hosp, Dept Resp Med, Nanjing 210002, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷 / 05期
关键词：
CANCER; MUTATIONS; GEFITINIB; CHEMOTHERAPY;
D O I：
10.21037/jtd.2018.04.162
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：E359 / E363
页数：5
相关论文
共 50 条
  • [1] Lung Adenocarcinoma Patient with EGFR Kinase Domain Duplication (KDD) and Its Response to Icotinib: A Case Report
    Wang, W.
    Xu, C.
    Tan, Q.
    Song, Z.
    Zhuang, W.
    Chen, Y.
    Xiong, L.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2261 - S2261
  • [2] Lung Adenocarcinoma Harboring EGFR Kinase Domain Duplication (EGFR-KDD) Confers Sensitivity to Osimertinib and Nivolumab: A Case Report
    Li, Jie
    Yan, Junrong
    Cao, Ran
    Du, Guanjun
    Zhao, Guofang
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] EGFR kinase domain duplication (EGFR-KDD) is activated by asymmetric intramolecular dimerization
    Du, Zhenfang
    Gallant, Jean-Nicolas
    Red-Brewer, Monica
    Brown, Benjamin
    Sheehan, Jonathan
    Meiler, Jens
    Lovly, Christine M.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [4] EGFR Kinase Domain Duplication (EGFR-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to Afatinib
    Gallant, Jean-Nicolas
    Sheehan, Jonathan H.
    Shaver, Timothy M.
    Bailey, Mark
    Lipson, Doron
    Chandramohan, Raghu
    Brewer, Monica Red
    York, Sally J.
    Kris, Mark G.
    Pietenpol, Jennifer A.
    Ladanyi, Marc
    Miller, Vincent A.
    Ali, Siraj M.
    Meiler, Jens
    Lovly, Christine M.
    [J]. CANCER DISCOVERY, 2015, 5 (11) : 1155 - 1163
  • [5] Lung adenocarcinoma patient with EGFR 19 exon insert mutation and its response to icotinib
    Zhu, You-cai
    Du, Kai-qi
    Wang, Wen-xian
    Song, Zheng-bo
    Xu, Chun-wei
    Chen, Gang
    Zhuang, Wu
    Lv, Tang-feng
    Song, Yong
    [J]. LUNG CANCER, 2018, 121 : 101 - 104
  • [6] The Landscape of Kinase Domain Duplication (KDD) in Chinese Lung Cancer Patients
    Wang, P.
    Wu, D.
    Xie, Y.
    Shi, X.
    Hou, T.
    Chen, S.
    Xiang, J.
    Shao, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S691 - S692
  • [7] EGFR-KDD with Duplication of Exons 18-26 Responding to Afatinib Treatment in a Patient with Lung Adenocarcinoma
    Qian, Y.
    Yu, G.
    Dong, L.
    Zhang, J.
    Wang, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S595 - S595
  • [8] A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib
    Xu, C.
    Wang, W.
    Zhang, Q.
    Wu, B.
    Zhuang, W.
    Zhu, Y.
    Chen, Y.
    Fang, M.
    Chen, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1032 - S1033
  • [9] Durable response to EGFR tyrosine kinase inhibitors in a patient with non-small cell lung cancer harboring an EGFR kinase domain duplication
    Hirokawa, Esuteru
    Watanabe, Satomi
    Sakai, Kazuko
    Takeda, Masayuki
    Sato, Chihiro
    Takahama, Takayuki
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    [J]. THORACIC CANCER, 2021, 12 (16) : 2283 - 2287
  • [10] Detection of an EGFR kinase domain duplication in a lung adenocarcinoma patient by liquid biopsy using hybrid capture based next generation sequencing
    Wiest, G.
    Kohlhaeufel, M.
    Mueller, J.
    Lakis, S.
    Wesseler, C.
    Mariotti, E.
    Zacherle, T.
    Leenders, F.
    Gloeckner, C.
    Heuckmann, J. M.
    Menon, R.
    Heukamp, L.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 89 - 89
12345